New Tobacco Research Study Results from National Center for Chronic Diseases Prevention and Health Promotion Described (Receipt of Cessation Treatments Among Medicaid Enrollees Trying To Quit Smoking): Tobacco Research

CDC & FDA Daily

2022 FEB 16 (NewsRx) -- By a News Reporter-Staff News Editor at CDC & FDA Daily -- New research on Tobacco Research is the subject of a report. According to news reporting originating in Atlanta, Georgia, by NewsRx journalists, research stated, “Cigarette smoking prevalence is higher among adults enrolled in Medicaid than adults with private health insurance. State Medicaid coverage of cessation treatments has been gradually improving in recent years; however, the extent to which this has translated into increased use of these treatments by Medicaid enrollees remains unknown.”

The news reporters obtained a quote from the research from National Center for Chronic Diseases Prevention and Health Promotion, “Using Medicaid Analytic eXtract (MAX) files, we estimated state-level receipt of smoking cessation treatments and associated spending among Medicaid fee-for service (FFS) enrollees who try to quit. MAX data are the only national person-level data set available for the Medicaid program. We used the most recent MAX data available for each state and the District of Columbia (ranging from 2010 to 2014) for this analysis. Among the 37 states with data, an average of 9.4% of FFS Medicaid smokers with a past-year quit attempt had claims for cessation medications, ranging from 0.2% (Arkansas) to 32.9% (Minnesota). Among the 20 states with data, an average of 2.7% of FFS Medicaid smokers with a past-year quit attempt received cessation counseling, ranging from 0.1% (Florida) to 5.6% (Missouri). Estimated Medicaid spending for cessation medications and counseling for these states totaled just over $13 million. If all Medicaid smokers who tried to quit were to have claims for cessation medications, projected annual Medicaid expenditures would total $0.8 billion, a small fraction of the amount ($45.9 billion) that Medicaid spends annually on treating smoking-related disease.”

According to the news reporters, the research concluded: “The receipt of cessation medications and counseling among FFS Medicaid enrollees was low and varied widely across states.”

This research has been peer-reviewed.

For more information on this research see: Receipt of Cessation Treatments Among Medicaid Enrollees Trying To Quit Smoking. Nicotine & Tobacco Research, 2021;23(6):1074-1078. Nicotine & Tobacco Research can be contacted at: Oxford Univ Press, Great Clarendon St, Oxford OX2 6DP, England. (Oxford University Press - http://www.oup.com/; Nicotine & Tobacco Research - ntr.oxfordjournals.org)

Our news correspondents report that additional information may be obtained by contacting Xu Wang, Centers for Disease Control and Prevention, Office on Smoking and Health, National Center for Chronic Diseases Prevention and Health Promotion, 4770 Buford Highway, S107-7, Atlanta, GA 30341, United States. Additional authors for this research include Stephen Babb, Xin Xu, Rebecca Glover-Kudon, Brian S. Armour and Leighton Ku.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1093/ntr/ntaa213. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.